Brian Henry, MD
Cardiovascular Disease · Pittsburgh, PANPI 1811124480
Payments from drug & device makers
Across 518 payments — averaging $519.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$98K
- Johnson & Johnson$59K
- CSL Behring$45K
- Boston Scientific$19K
- Boehringer Ingelheim$16K
- Sanofi-aventis U.S. LLC$9K
- plus $23K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer(2 entities) | 118 | $97,957 |
| Johnson & Johnson | 104 | $59,263 |
| CSL Behring | 44 | $45,242 |
| Boston Scientific | 31 | $18,741 |
| Boehringer Ingelheim | 25 | $15,863 |
| Sanofi-aventis U.S. LLC | 13 | $9,228 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $7,315 |
| Alnylam Pharmaceuticals Inc. | 18 | $4,427 |
| Lilly USA, LLC | 5 | $4,088 |
| E.r. Squibb & Sons, L.L.C. | 18 | $3,068 |
| Amgen | 29 | $849 |
| Abbott | 11 | $843 |
| Novartis | 18 | $402 |
| AstraZeneca | 10 | $282 |
| Novo Nordisk | 4 | $164 |
| Corcym Inc | 1 | $152 |
| Philips North America LLC | 8 | $135 |
| Kowa Pharmaceuticals America, Inc. | 1 | $127 |
| Heartflow, Inc. | 5 | $106 |
| Baxter Healthcare | 2 | $102 |
| Regeneron Healthcare Solutions, Inc. | 6 | $95 |
| Bridgebio Pharma, Inc. | 3 | $77 |
| Esperion Therapeutics, Inc. | 4 | $75 |
| Janssen Scientific Affairs, LLC | 2 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 1 | $41 |
| Impulse Dynamics (USA) Inc. | 1 | $39 |
| Irhythm Technologies, Inc. | 2 | $35 |
| GSK | 1 | $34 |
| Vital Connect, Inc | 1 | $33 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Cardiovascular Systems Inc. | 1 | $26 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Medtronic | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $18 |
| Bayer | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $13 |
How this compares
$269,033 in reported general payments places this provider in the 95th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Pittsburgh
- Stephen ChanPittsburgh$1.2M
- Rewat CholapraneePittsburgh$598K
- George GabrielPittsburgh$584K
- Indu PoornimaPittsburgh$422K
- Timothy WongPittsburgh$265K
- Mark GreathousePittsburgh$243K
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.